BlackRock Fund Advisors - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 75 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$27,829,000
+179.1%
1,360,818
+104.7%
0.01%
+150.0%
Q3 2016$9,971,000
+48.0%
664,746
+6.8%
0.00%
+100.0%
Q2 2016$6,736,000
+86.3%
622,563
+133.5%
0.00%0.0%
Q1 2016$3,615,000
-30.3%
266,606
-5.1%
0.00%0.0%
Q4 2015$5,184,000
-22.9%
280,954
+5.7%
0.00%
-50.0%
Q3 2015$6,728,000265,7130.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders